Attenuon, LLC

University of Michigan

Melissa L P Price

Robert J Ternansky

Andrew P Mazar

Patricia L Gladstone

Amy Lynn Allan

Dimitri Coucouvanis

Fernando Donate

Steven Pirie-Shepherd

Sean M O'Hare

The current invention provides novel thiotungstate derivatives, methods of making novel thiotungstate derivatives, pharmaceutical compositions of novel thiotungstate derivatives, methods of using novel thiotungstate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders and obesity and methods of using pharmaceutical compositions of thiotungstate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-&#x3ba;B dysregulation.

Thiotungstate analogues and uses thereof

The current invention provides novel thiomolybdate derivatives, methods of making novel thiomolybdate derivatives, pharmaceutical compositions of novel thiomolybdate derivatives, methods of using novel thiomolybdate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-&#x3ba;B dysregulation and methods of using pharmaceutical compositions of thiomolybdate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-&#x3ba;B dysregulation.

Thiomolybdate analogues and uses thereof

Growing community of inventors

Cardiff, CA, United States of America

Melissa L P Price